2021 Form 10-K Financial Statement

#000149315222008546 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $21.46M $1.320M $4.320M
YoY Change 396.67% 91.3% 27.06%
% of Gross Profit
Research & Development $6.745M $1.820M $7.960M
YoY Change -15.26%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $30.00K
YoY Change -100.0% -100.0% -57.14%
% of Gross Profit
Operating Expenses $28.81M $3.150M $12.28M
YoY Change 134.61% 356.52% 262.24%
Operating Profit -$28.81M -$3.150M -$12.28M
YoY Change 134.61% 356.52% 262.24%
Interest Expense $5.710K $40.00K $170.0K
YoY Change -96.64% 100.0% 70.0%
% of Operating Profit
Other Income/Expense, Net -$1.079M
YoY Change
Pretax Income -$29.89M -$3.110M -$12.15M
YoY Change 146.0% 357.35% 259.47%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$29.89M -$3.290M -$17.58M
YoY Change 70.02% 145.52% 351.93%
Net Earnings / Revenue
Basic Earnings Per Share -$0.85
Diluted Earnings Per Share -$853.6K -$503.1K -$4.980M
COMMON SHARES
Basic Shares Outstanding 35.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.56M $35.34M $35.34M
YoY Change -67.29% 265.08% 265.08%
Cash & Equivalents $556.0K $148.3K
Short-Term Investments $11.00M $16.72M $16.72M
Other Short-Term Assets $1.106M $300.0K $300.0K
YoY Change 268.78% -23.08% -23.08%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.67M $36.84M $36.84M
YoY Change -65.62% 257.32% 257.32%
LONG-TERM ASSETS
Property, Plant & Equipment $149.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.500M
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $12.15M $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $12.67M $36.84M $36.84M
Total Long-Term Assets $12.15M $0.00 $0.00
Total Assets $24.81M $36.84M $36.84M
YoY Change -32.65% 238.6% 238.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $867.5K $2.200M $2.200M
YoY Change -60.57% 233.33% 233.33%
Accrued Expenses $172.4K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $1.040M $2.260M $2.260M
YoY Change -53.99% 47.71% 47.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $125.9K
YoY Change
Total Long-Term Liabilities $125.9K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.040M $2.260M $2.260M
Total Long-Term Liabilities $125.9K $0.00 $0.00
Total Liabilities $1.166M $2.260M $2.260M
YoY Change -48.42% 47.71% 47.71%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.65M -$5.257M $34.58M
YoY Change
Total Liabilities & Shareholders Equity $24.81M $36.84M $36.84M
YoY Change -32.65% 238.6% 238.6%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$29.89M -$3.290M -$17.58M
YoY Change 70.02% 145.52% 351.93%
Depreciation, Depletion And Amortization $0.00 $0.00 $30.00K
YoY Change -100.0% -100.0% -57.14%
Cash From Operating Activities -$19.52M -$3.080M -$11.92M
YoY Change 63.73% 516.0% 288.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $19.85M -$10.97M -$8.760M
YoY Change -326.61% 73.85% 122.34%
Cash From Investing Activities $19.85M -$10.97M
YoY Change 73.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 73.53K 16.36M 38.67M
YoY Change -99.81% 134.72% 454.81%
NET CHANGE
Cash From Operating Activities -19.52M -3.080M -11.92M
Cash From Investing Activities 19.85M -10.97M
Cash From Financing Activities 73.53K 16.36M 38.67M
Net Change In Cash 407.7K 2.310M $0.00
YoY Change 1343.75% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$19.52M -$3.080M -$11.92M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
USD
CY2020 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
USD
CY2020 MYMD Gain On Debt Forgiveness
GainOnDebtForgiveness
USD
CY2020 MYMD Uninsured Casualty Losses
UninsuredCasualtyLosses
USD
CY2021 MYMD Issuance Of Postmerger Common Shares At Exchange Ratio Per Premerger Common Share
IssuanceOfPostmergerCommonSharesAtExchangeRatioPerPremergerCommonShare
USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
USD
CY2020Q4 us-gaap Goodwill
Goodwill
USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
USD
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
USD
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
USD
CY2020Q4 MYMD Due To Shareholders Non Current
DueToShareholdersNonCurrent
USD
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
USD
CY2020 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2020 MYMD Marketable Securities Unrealized Loss
MarketableSecuritiesUnrealizedLoss
USD
CY2020 MYMD Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
USD
CY2021 MYMD Common Stock Options
CommonStockOptions
USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
USD
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
CY2020 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2021 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
USD
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2021 us-gaap Stock Issued1
StockIssued1
USD
CY2020 MYMD Other Asset Investment
OtherAssetInvestment
USD
CY2020 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
USD
CY2021Q4 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
USD
CY2021Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
USD
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
USD
CY2021Q4 MYMD Interest Payable Related Party
InterestPayableRelatedParty
USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021 MYMD Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Expired In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrExpiredInPeriodWeightedAverageGrantDateFairValue
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD

Files In Submission

Name View Source Status
0001493152-22-008546-index-headers.html Edgar Link pending
0001493152-22-008546-index.html Edgar Link pending
0001493152-22-008546.txt Edgar Link pending
0001493152-22-008546-xbrl.zip Edgar Link pending
ex10-66.htm Edgar Link pending
ex10-67.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex4-12.htm Edgar Link pending
f10k_001.jpg Edgar Link pending
f10k_002.jpg Edgar Link pending
f10k_003.jpg Edgar Link pending
f10k_004.jpg Edgar Link pending
f10k_005.jpg Edgar Link pending
f10k_006.jpg Edgar Link pending
f10k_007.jpg Edgar Link pending
f10k_008.jpg Edgar Link pending
f10k_009.jpg Edgar Link pending
f10k_010.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
mymd-20211231.xsd Edgar Link pending
mymd-20211231_cal.xml Edgar Link unprocessable
mymd-20211231_def.xml Edgar Link unprocessable
mymd-20211231_lab.xml Edgar Link unprocessable
mymd-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending